Report Detail

Request for Sample of this report

Pharma & Healthcare Global Meglinitide Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

  • RnM4516664
    • |
  • 27 February, 2023
    • |
  • Global
    • |
  • 113 Pages
    • |
  • GIR (Global Info Research)
    • |
  • Pharma & Healthcare

According to our (Global Info Research) latest study, the global Meglinitide market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Meglinitides are the agents used to treat type 2 diabetes. They act same as β-cell receptor as sulphonylureas, but have a different chemical structure. They are novel class of non-sulfonylurea insulin secretagogues characterized by very rapid onset and abbreviated duration of action. They act by stimulating pancreas to release insulin in response to meal. In functioning pancreatic beta cells, it also closes ATP-dependent potassium dependent channels. Due to this depolarization of beta cells, opening of calcium channels resulting in influx of calcium and Increased intracellular calcium induces insulin secretion.
This report is a detailed and comprehensive analysis for global Meglinitide market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Meglinitide market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Meglinitide market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Meglinitide market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Meglinitide market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Meglinitide
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Meglinitide market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Pfizer Inc, F. Hoffmann-La Roche Ltd, Mylan N.V, Fresenius Kabi AG and Hikma Pharmaceuticals PLC, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Meglinitide market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Repaglinide
Nateglinide
Other
Market segment by Application
Type II Diabetes
Others
Major players covered
Pfizer Inc
F. Hoffmann-La Roche Ltd
Mylan N.V
Fresenius Kabi AG
Hikma Pharmaceuticals PLC
Novartis AG
Teva Pharmaceutical Industries Ltd.
Bristol Myers Squibb Company
GSK Plc
Bayer AG
Sun Pharmaceutical Industries Ltd
Novartis AG
Lupin
Cipla Inc
Aurobindo Pharma
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Meglinitide product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Meglinitide, with price, sales, revenue and global market share of Meglinitide from 2018 to 2023.
Chapter 3, the Meglinitide competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Meglinitide breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Meglinitide market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Meglinitide.
Chapter 14 and 15, to describe Meglinitide sales channel, distributors, customers, research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope of Meglinitide
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Meglinitide Consumption Value by Type: 2018 Versus 2022 Versus 2029
    • 1.3.2 Repaglinide
    • 1.3.3 Nateglinide
    • 1.3.4 Other
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Meglinitide Consumption Value by Application: 2018 Versus 2022 Versus 2029
    • 1.4.2 Type II Diabetes
    • 1.4.3 Others
  • 1.5 Global Meglinitide Market Size & Forecast
    • 1.5.1 Global Meglinitide Consumption Value (2018 & 2022 & 2029)
    • 1.5.2 Global Meglinitide Sales Quantity (2018-2029)
    • 1.5.3 Global Meglinitide Average Price (2018-2029)

2 Manufacturers Profiles

  • 2.1 Pfizer Inc
    • 2.1.1 Pfizer Inc Details
    • 2.1.2 Pfizer Inc Major Business
    • 2.1.3 Pfizer Inc Meglinitide Product and Services
    • 2.1.4 Pfizer Inc Meglinitide Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.1.5 Pfizer Inc Recent Developments/Updates
  • 2.2 F. Hoffmann-La Roche Ltd
    • 2.2.1 F. Hoffmann-La Roche Ltd Details
    • 2.2.2 F. Hoffmann-La Roche Ltd Major Business
    • 2.2.3 F. Hoffmann-La Roche Ltd Meglinitide Product and Services
    • 2.2.4 F. Hoffmann-La Roche Ltd Meglinitide Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.2.5 F. Hoffmann-La Roche Ltd Recent Developments/Updates
  • 2.3 Mylan N.V
    • 2.3.1 Mylan N.V Details
    • 2.3.2 Mylan N.V Major Business
    • 2.3.3 Mylan N.V Meglinitide Product and Services
    • 2.3.4 Mylan N.V Meglinitide Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.3.5 Mylan N.V Recent Developments/Updates
  • 2.4 Fresenius Kabi AG
    • 2.4.1 Fresenius Kabi AG Details
    • 2.4.2 Fresenius Kabi AG Major Business
    • 2.4.3 Fresenius Kabi AG Meglinitide Product and Services
    • 2.4.4 Fresenius Kabi AG Meglinitide Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.4.5 Fresenius Kabi AG Recent Developments/Updates
  • 2.5 Hikma Pharmaceuticals PLC
    • 2.5.1 Hikma Pharmaceuticals PLC Details
    • 2.5.2 Hikma Pharmaceuticals PLC Major Business
    • 2.5.3 Hikma Pharmaceuticals PLC Meglinitide Product and Services
    • 2.5.4 Hikma Pharmaceuticals PLC Meglinitide Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.5.5 Hikma Pharmaceuticals PLC Recent Developments/Updates
  • 2.6 Novartis AG
    • 2.6.1 Novartis AG Details
    • 2.6.2 Novartis AG Major Business
    • 2.6.3 Novartis AG Meglinitide Product and Services
    • 2.6.4 Novartis AG Meglinitide Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.6.5 Novartis AG Recent Developments/Updates
  • 2.7 Teva Pharmaceutical Industries Ltd.
    • 2.7.1 Teva Pharmaceutical Industries Ltd. Details
    • 2.7.2 Teva Pharmaceutical Industries Ltd. Major Business
    • 2.7.3 Teva Pharmaceutical Industries Ltd. Meglinitide Product and Services
    • 2.7.4 Teva Pharmaceutical Industries Ltd. Meglinitide Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.7.5 Teva Pharmaceutical Industries Ltd. Recent Developments/Updates
  • 2.8 Bristol Myers Squibb Company
    • 2.8.1 Bristol Myers Squibb Company Details
    • 2.8.2 Bristol Myers Squibb Company Major Business
    • 2.8.3 Bristol Myers Squibb Company Meglinitide Product and Services
    • 2.8.4 Bristol Myers Squibb Company Meglinitide Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.8.5 Bristol Myers Squibb Company Recent Developments/Updates
  • 2.9 GSK Plc
    • 2.9.1 GSK Plc Details
    • 2.9.2 GSK Plc Major Business
    • 2.9.3 GSK Plc Meglinitide Product and Services
    • 2.9.4 GSK Plc Meglinitide Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.9.5 GSK Plc Recent Developments/Updates
  • 2.10 Bayer AG
    • 2.10.1 Bayer AG Details
    • 2.10.2 Bayer AG Major Business
    • 2.10.3 Bayer AG Meglinitide Product and Services
    • 2.10.4 Bayer AG Meglinitide Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.10.5 Bayer AG Recent Developments/Updates
  • 2.11 Sun Pharmaceutical Industries Ltd
    • 2.11.1 Sun Pharmaceutical Industries Ltd Details
    • 2.11.2 Sun Pharmaceutical Industries Ltd Major Business
    • 2.11.3 Sun Pharmaceutical Industries Ltd Meglinitide Product and Services
    • 2.11.4 Sun Pharmaceutical Industries Ltd Meglinitide Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.11.5 Sun Pharmaceutical Industries Ltd Recent Developments/Updates
  • 2.12 Novartis AG
    • 2.12.1 Novartis AG Details
    • 2.12.2 Novartis AG Major Business
    • 2.12.3 Novartis AG Meglinitide Product and Services
    • 2.12.4 Novartis AG Meglinitide Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.12.5 Novartis AG Recent Developments/Updates
  • 2.13 Lupin
    • 2.13.1 Lupin Details
    • 2.13.2 Lupin Major Business
    • 2.13.3 Lupin Meglinitide Product and Services
    • 2.13.4 Lupin Meglinitide Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.13.5 Lupin Recent Developments/Updates
  • 2.14 Cipla Inc
    • 2.14.1 Cipla Inc Details
    • 2.14.2 Cipla Inc Major Business
    • 2.14.3 Cipla Inc Meglinitide Product and Services
    • 2.14.4 Cipla Inc Meglinitide Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.14.5 Cipla Inc Recent Developments/Updates
  • 2.15 Aurobindo Pharma
    • 2.15.1 Aurobindo Pharma Details
    • 2.15.2 Aurobindo Pharma Major Business
    • 2.15.3 Aurobindo Pharma Meglinitide Product and Services
    • 2.15.4 Aurobindo Pharma Meglinitide Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.15.5 Aurobindo Pharma Recent Developments/Updates

3 Competitive Environment: Meglinitide by Manufacturer

  • 3.1 Global Meglinitide Sales Quantity by Manufacturer (2018-2023)
  • 3.2 Global Meglinitide Revenue by Manufacturer (2018-2023)
  • 3.3 Global Meglinitide Average Price by Manufacturer (2018-2023)
  • 3.4 Market Share Analysis (2022)
    • 3.4.1 Producer Shipments of Meglinitide by Manufacturer Revenue ($MM) and Market Share (%): 2022
    • 3.4.2 Top 3 Meglinitide Manufacturer Market Share in 2022
    • 3.4.2 Top 6 Meglinitide Manufacturer Market Share in 2022
  • 3.5 Meglinitide Market: Overall Company Footprint Analysis
    • 3.5.1 Meglinitide Market: Region Footprint
    • 3.5.2 Meglinitide Market: Company Product Type Footprint
    • 3.5.3 Meglinitide Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Meglinitide Market Size by Region
    • 4.1.1 Global Meglinitide Sales Quantity by Region (2018-2029)
    • 4.1.2 Global Meglinitide Consumption Value by Region (2018-2029)
    • 4.1.3 Global Meglinitide Average Price by Region (2018-2029)
  • 4.2 North America Meglinitide Consumption Value (2018-2029)
  • 4.3 Europe Meglinitide Consumption Value (2018-2029)
  • 4.4 Asia-Pacific Meglinitide Consumption Value (2018-2029)
  • 4.5 South America Meglinitide Consumption Value (2018-2029)
  • 4.6 Middle East and Africa Meglinitide Consumption Value (2018-2029)

5 Market Segment by Type

  • 5.1 Global Meglinitide Sales Quantity by Type (2018-2029)
  • 5.2 Global Meglinitide Consumption Value by Type (2018-2029)
  • 5.3 Global Meglinitide Average Price by Type (2018-2029)

6 Market Segment by Application

  • 6.1 Global Meglinitide Sales Quantity by Application (2018-2029)
  • 6.2 Global Meglinitide Consumption Value by Application (2018-2029)
  • 6.3 Global Meglinitide Average Price by Application (2018-2029)

7 North America

  • 7.1 North America Meglinitide Sales Quantity by Type (2018-2029)
  • 7.2 North America Meglinitide Sales Quantity by Application (2018-2029)
  • 7.3 North America Meglinitide Market Size by Country
    • 7.3.1 North America Meglinitide Sales Quantity by Country (2018-2029)
    • 7.3.2 North America Meglinitide Consumption Value by Country (2018-2029)
    • 7.3.3 United States Market Size and Forecast (2018-2029)
    • 7.3.4 Canada Market Size and Forecast (2018-2029)
    • 7.3.5 Mexico Market Size and Forecast (2018-2029)

8 Europe

  • 8.1 Europe Meglinitide Sales Quantity by Type (2018-2029)
  • 8.2 Europe Meglinitide Sales Quantity by Application (2018-2029)
  • 8.3 Europe Meglinitide Market Size by Country
    • 8.3.1 Europe Meglinitide Sales Quantity by Country (2018-2029)
    • 8.3.2 Europe Meglinitide Consumption Value by Country (2018-2029)
    • 8.3.3 Germany Market Size and Forecast (2018-2029)
    • 8.3.4 France Market Size and Forecast (2018-2029)
    • 8.3.5 United Kingdom Market Size and Forecast (2018-2029)
    • 8.3.6 Russia Market Size and Forecast (2018-2029)
    • 8.3.7 Italy Market Size and Forecast (2018-2029)

9 Asia-Pacific

  • 9.1 Asia-Pacific Meglinitide Sales Quantity by Type (2018-2029)
  • 9.2 Asia-Pacific Meglinitide Sales Quantity by Application (2018-2029)
  • 9.3 Asia-Pacific Meglinitide Market Size by Region
    • 9.3.1 Asia-Pacific Meglinitide Sales Quantity by Region (2018-2029)
    • 9.3.2 Asia-Pacific Meglinitide Consumption Value by Region (2018-2029)
    • 9.3.3 China Market Size and Forecast (2018-2029)
    • 9.3.4 Japan Market Size and Forecast (2018-2029)
    • 9.3.5 Korea Market Size and Forecast (2018-2029)
    • 9.3.6 India Market Size and Forecast (2018-2029)
    • 9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
    • 9.3.8 Australia Market Size and Forecast (2018-2029)

10 South America

  • 10.1 South America Meglinitide Sales Quantity by Type (2018-2029)
  • 10.2 South America Meglinitide Sales Quantity by Application (2018-2029)
  • 10.3 South America Meglinitide Market Size by Country
    • 10.3.1 South America Meglinitide Sales Quantity by Country (2018-2029)
    • 10.3.2 South America Meglinitide Consumption Value by Country (2018-2029)
    • 10.3.3 Brazil Market Size and Forecast (2018-2029)
    • 10.3.4 Argentina Market Size and Forecast (2018-2029)

11 Middle East & Africa

  • 11.1 Middle East & Africa Meglinitide Sales Quantity by Type (2018-2029)
  • 11.2 Middle East & Africa Meglinitide Sales Quantity by Application (2018-2029)
  • 11.3 Middle East & Africa Meglinitide Market Size by Country
    • 11.3.1 Middle East & Africa Meglinitide Sales Quantity by Country (2018-2029)
    • 11.3.2 Middle East & Africa Meglinitide Consumption Value by Country (2018-2029)
    • 11.3.3 Turkey Market Size and Forecast (2018-2029)
    • 11.3.4 Egypt Market Size and Forecast (2018-2029)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
    • 11.3.6 South Africa Market Size and Forecast (2018-2029)

12 Market Dynamics

  • 12.1 Meglinitide Market Drivers
  • 12.2 Meglinitide Market Restraints
  • 12.3 Meglinitide Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry
  • 12.5 Influence of COVID-19 and Russia-Ukraine War
    • 12.5.1 Influence of COVID-19
    • 12.5.2 Influence of Russia-Ukraine War

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Meglinitide and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Meglinitide
  • 13.3 Meglinitide Production Process
  • 13.4 Meglinitide Industrial Chain

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Meglinitide Typical Distributors
  • 14.3 Meglinitide Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Meglinitide. Industry analysis & Market Report on Meglinitide is a syndicated market report, published as Global Meglinitide Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029. It is complete Research Study and Industry Analysis of Meglinitide market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,724.84
    		4,087.26
    		5,449.68
    		3,201.60
    		4,802.40
    		6,403.20
    		546,499.20
    		819,748.80
    		1,092,998.40
    		289,501.20
    		434,251.80
    		579,002.40
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo